Coronary vasoconstriction produced by vasopressin in anesthetized goats. Role of vasopressin V 1 and V 2 receptors and nitric oxide

By Fernandez N.   Garca J.L.   Garca-Villalon A.L.   Monge L.   Gomez B.   Dieguez G.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 225-233

Elsevier

Access to resources Recommend Favorite

Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V 1A receptors

By Chen Y.L.   Shepherd C.   Spinelli W.   Lai F.M.  

European Journal of Pharmacology, Vol. 376, Iss. 1, 1999-07 ,pp. : 45-51

Elsevier

Access to resources Recommend Favorite

Molecular pharmacology of NMDA receptors

By Williams K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 169-169

Elsevier

Access to resources Recommend Favorite

Properties of a new radioiodinated antagonist for human vasopressin V 2 and V 1a receptors

By Ala Y.   Morin D.   Mahe E.   Cotte N.   Mouillac B.   Jard S.   Barberis C.   Tribollet E.   Dreifuss J.-J.   Sawyer W.H.   Wo N.C.   Chan W.Y.   Kolodziejczyk A.S.   Cheng L.L.   Manning M.  

European Journal of Pharmacology, Vol. 331, Iss. 2, 1997-07 ,pp. : 285-293

Elsevier

Access to resources Recommend Favorite

Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists

By Hagiwara Yohsuke  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. : 951-964

Informa Healthcare

Access to resources Recommend Favorite